-
India's Modi faces key test as vote count underway
-
Japan PM says oil crisis has 'enormous impact' in Asia-Pacific
-
Badminton no.1 An brings 'fire' as South Korea win Uber Cup
-
Saka sparks Arsenal attack into life ahead of Atletico showdown
-
Atletico aim to show Alvarez their ambition in Arsenal semi
-
Seoul, Taipei hit records as Asian stocks track Wall St tech rally
-
Boeing faces civil trial over 737 MAX crash
-
Australian inquiry opens public hearings into Bondi Beach shooting
-
Iran warns of ceasefire violation as US plans to escort Hormuz ships
-
North Korean club to play rare football match in South
-
Pistons rout Magic to cap comeback, book NBA playoff clash with Cavaliers
-
Japan, Australia discuss energy, critical minerals
-
Village braces for closure of Spain's largest nuclear plant
-
GameStop makes $56 billion takeover bid for eBay
-
Ex-NY mayor Giuliani hospitalized in 'critical' condition: spokesman
-
Europe, Canada leaders hold Yerevan talks in Trump's shadow
-
'No pilgrims': regional war hushes Iraq's holy cities
-
Israel court extends detention of two Gaza flotilla activists
-
Massive search continues for two missing US soldiers in Morocco
-
Players keep up battle with tennis majors as they decry Roland Garros prize money
-
EB5 United Surpasses 800 I-526E Approvals in Post-RIA EB-5 Landscape
-
Pistons rout Magic to complete comeback, advance in NBA playoffs
-
Trump says US and Iran in 'positive' talks, unveils plan to escort Hormuz ships
-
Talisman Endrick fires resurgent Lyon into third in France
-
Verstappen laments spin and struggle for pace in Miami
-
Teen Antonelli wins again in Miami to extend title race lead
-
Ferrari's Leclerc admits he threw away Miami podium finish
-
Cristian Chivu, a winner with Inter on the pitch and in the dugout
-
Key players from Inter Milan's Serie A title triumph
-
No.4 Young cruises to PGA title at Doral
-
Vinicius double delays Barca title as Real Madrid down Espanyol
-
Inter Milan win Italian title for third time in six seasons
-
Spurs solved mental frailty to boost survival bid: De Zerbi
-
Miami champ Antonelli shrugs off success, vows 'back to work'
-
Man Utd beat Liverpool, Spurs climb out of relegation zone
-
Spurs out of relegation zone after vital win at Villa
-
No.1 Korda cruises to LPGA Mexico crown
-
Thompson-Herah shines at world relays, Tebogo helps Botswana to win
-
Three die on Atlantic cruise ship from suspected hantavirus: WHO
-
Germany's Merz says not 'giving up on working with Donald Trump'
-
Mercedes' Kimi Antonelli wins Miami Grand Prix
-
Man Utd job feels 'natural' to Carrick
-
Ferguson taken to hospital before Man Utd win against Liverpool
-
'Devil Wears Prada 2' takes top spot in N. America box office
-
Iran weighs US response to peace plan after warning against military action
-
Gladbach sink Dortmund, St Pauli edge closer to drop
-
Rubio to visit Rome, meet Pope Leo after Trump row
-
Kyiv hits Russian oil sites as eight killed in both countries
-
Iran says US military operation 'impossible' as Trump mulls peace proposal
-
Man Utd beat Liverpool to secure Champions League place
Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
A.O.Scott--AT